-
1
-
-
0031031977
-
Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking
-
Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997;24:2-17.
-
(1997)
J Clin Gastroenterol
, vol.24
, pp. 2-17
-
-
Kurata, J.H.1
Nogawa, A.N.2
-
2
-
-
0030015717
-
Gastrointestinal tract complications of nonsteroidal antiinflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study
-
Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal antiinflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med 1996;156:1530-6.
-
(1996)
Arch Intern Med
, vol.156
, pp. 1530-1536
-
-
Singh, G.1
Ramey, D.R.2
Morfeld, D.3
Shi, H.4
Hatoum, H.T.5
Fries, J.F.6
-
3
-
-
0025998097
-
Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-analysis
-
Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-96.
-
(1991)
Ann Intern Med
, vol.115
, pp. 787-796
-
-
Gabriel, S.E.1
Jaakkimainen, L.2
Bombardier, C.3
-
4
-
-
0025853360
-
Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons
-
Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray LA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
-
(1991)
Ann Intern Med
, vol.114
, pp. 257-263
-
-
Griffin, M.R.1
Piper, J.M.2
Daugherty, J.R.3
Snowden, M.4
Ray, L.A.5
-
5
-
-
8944227048
-
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis
-
Henry D, Lim LLY, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-6.
-
(1996)
BMJ
, vol.312
, pp. 1563-1566
-
-
Henry, D.1
Lim, L.L.Y.2
Garcia Rodriguez, L.A.3
-
6
-
-
0026024439
-
Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers
-
Lancaster-Smith MJ, Jaderberg ME, Jackson DA. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut 1991;32:252-5.
-
(1991)
Gut
, vol.32
, pp. 252-255
-
-
Lancaster-Smith, M.J.1
Jaderberg, M.E.2
Jackson, D.A.3
-
7
-
-
0024552757
-
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer
-
Walan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989;320:69-75.
-
(1989)
N Engl J Med
, vol.320
, pp. 69-75
-
-
Walan, A.1
Bader, J.P.2
Classen, M.3
-
8
-
-
0030961530
-
Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration
-
Hudson N, Taha AS, Russell RI, et al. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology 1997;112:1817-22.
-
(1997)
Gastroenterology
, vol.112
, pp. 1817-1822
-
-
Hudson, N.1
Taha, A.S.2
Russell, R.I.3
-
9
-
-
0024452662
-
Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine
-
Daneshmend TK, Prichard PJ, Bhaskar NK, Millns PJ, Hawkey CJ. Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine. Gastroenterology 1989;97:944-9.
-
(1989)
Gastroenterology
, vol.97
, pp. 944-949
-
-
Daneshmend, T.K.1
Prichard, P.J.2
Bhaskar, N.K.3
Millns, P.J.4
Hawkey, C.J.5
-
10
-
-
0023262313
-
Cimetidine therapy in nonsteroidal antiinflammatory drug gastropathy. Double-blind long-term evaluation
-
Roth SH, Bennett RE, Mitchell CS, Hartman RJ. Cimetidine therapy in nonsteroidal antiinflammatory drug gastropathy. Double-blind long-term evaluation. Arch Intern Med 1987;147:1798-801.
-
(1987)
Arch Intern Med
, vol.147
, pp. 1798-1801
-
-
Roth, S.H.1
Bennett, R.E.2
Mitchell, C.S.3
Hartman, R.J.4
-
11
-
-
0022649723
-
The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs
-
Davies J, Collins AJ, Dixon SA. The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs: Br J Rheumatol 1986;25:54-8.
-
(1986)
Br J Rheumatol
, vol.25
, pp. 54-58
-
-
Davies, J.1
Collins, A.J.2
Dixon, S.A.3
-
12
-
-
0023706934
-
Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine
-
Ehsanullah RSB, Page MC, Tildesley G, Wood JR. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 1988;297:1017-21.
-
(1988)
BMJ
, vol.297
, pp. 1017-1021
-
-
Ehsanullah, R.S.B.1
Page, M.C.2
Tildesley, G.3
Wood, J.R.4
-
13
-
-
0024506386
-
Effect of ranitidine gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs
-
Robinson MG, Griffin JW Jr, Bowers J, et al. Effect of ranitidine gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 1989;34:424-8.
-
(1989)
Dig Dis Sci
, vol.34
, pp. 424-428
-
-
Robinson, M.G.1
Griffin Jr., J.W.2
Bowers, J.3
-
14
-
-
9344236529
-
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs
-
Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996;334:1435-9.
-
(1996)
N Engl J Med
, vol.334
, pp. 1435-1439
-
-
Taha, A.S.1
Hudson, N.2
Hawkey, C.J.3
-
15
-
-
0025146273
-
Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine
-
Nwokolo CU, Smith JT, Gavey C, Sawyerr A, Pounder RE. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment Pharmacol Ther 1990;4(Suppl 1): 29-45.
-
(1990)
Aliment Pharmacol Ther
, vol.4
, Issue.1 SUPPL.
, pp. 29-45
-
-
Nwokolo, C.U.1
Smith, J.T.2
Gavey, C.3
Sawyerr, A.4
Pounder, R.E.5
-
18
-
-
0032510378
-
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs
-
Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group
-
Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998;338:727-34.
-
(1998)
N Engl J Med
, vol.338
, pp. 727-734
-
-
Hawkey, C.J.1
Karrasch, J.A.2
Szczepanski, L.3
-
19
-
-
0032510315
-
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs
-
Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group
-
Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998;338:719-26.
-
(1998)
N Engl J Med
, vol.338
, pp. 719-726
-
-
Yeomans, N.D.1
Tulassay, Z.2
Juhasz, L.3
-
20
-
-
0029162250
-
Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial
-
Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:241-9.
-
(1995)
Ann Intern Med
, vol.123
, pp. 241-249
-
-
Silverstein, F.E.1
Graham, D.Y.2
Senior, J.R.3
-
21
-
-
0027933764
-
Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial
-
Elliott SL, Yeomans ND, Buchanan RR, Smallwood RA. Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial. Scand J Rheumatol 1994;23:171-6.
-
(1994)
Scand J Rheumatol
, vol.23
, pp. 171-176
-
-
Elliott, S.L.1
Yeomans, N.D.2
Buchanan, R.R.3
Smallwood, R.A.4
-
22
-
-
0025345299
-
Abolition by omeprazole of aspirin induced gastric mucosal injury in man
-
Daneshmend TK, Stein AG, Bhaskar NK, Hawkey CJ. Abolition by omeprazole of aspirin induced gastric mucosal injury in man. Gut 1990;31:514-7.
-
(1990)
Gut
, vol.31
, pp. 514-517
-
-
Daneshmend, T.K.1
Stein, A.G.2
Bhaskar, N.K.3
Hawkey, C.J.4
-
24
-
-
0030016432
-
Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study
-
Ekstrom P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol 1996;31:753-8.
-
(1996)
Scand J Gastroenterol
, vol.31
, pp. 753-758
-
-
Ekstrom, P.1
Carling, L.2
Wetterhus, S.3
-
25
-
-
0031975071
-
Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users
-
Cullen D, Bardhan KD, Eisner M, et al. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther 1998;12:135-40.
-
(1998)
Aliment Pharmacol Ther
, vol.12
, pp. 135-140
-
-
Cullen, D.1
Bardhan, K.D.2
Eisner, M.3
-
26
-
-
0023617192
-
Acid suppression in duodenal ulcer: A meta-analysis to define optimal dosing with antisecretory drugs
-
Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987;28:1120-7.
-
(1987)
Gut
, vol.28
, pp. 1120-1127
-
-
Jones, D.B.1
Howden, C.W.2
Burget, D.W.3
Kerr, G.D.4
Hunt, R.H.5
-
27
-
-
0025368161
-
The relationship between suppression of acidity and gastric ulcer healing rates
-
Howden CW, Hunt RH. The relationship between suppression of acidity and gastric ulcer healing rates. Aliment Pharmacol Ther 1990;4:25-33.
-
(1990)
Aliment Pharmacol Ther
, vol.4
, pp. 25-33
-
-
Howden, C.W.1
Hunt, R.H.2
-
28
-
-
0032579940
-
Mechanism of action of nonsteroidal antiinflammatory drugs
-
Vane JR, Botting RM. Mechanism of action of nonsteroidal antiinflammatory drugs. Am J Med 1998;104(Suppl 3A):2S-8S.
-
(1998)
Am J Med
, vol.104
, Issue.SUPPL. 3A
-
-
Vane, J.R.1
Botting, R.M.2
-
29
-
-
0032579896
-
Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs
-
Schmassmann A. Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs. Am J Med 1998;104(Suppl 3A):43S-51S.
-
(1998)
Am J Med
, vol.104
, Issue.SUPPL. 3A
-
-
Schmassmann, A.1
-
30
-
-
0028968789
-
Nitric oxide-releasing NSAIDS: A novel class of GI-sparing anti-inflammatory drugs
-
Wallace JL, Pittman QJ, Cirino G. Nitric oxide-releasing NSAIDS: a novel class of GI-sparing anti-inflammatory drugs. Agents Actions Suppl 1995;46:121-9.
-
(1995)
Agents Actions Suppl
, vol.46
, pp. 121-129
-
-
Wallace, J.L.1
Pittman, Q.J.2
Cirino, G.3
-
31
-
-
0008915459
-
Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat
-
Muscara MN, McKnight W, Del Soldato P, Wallace JL. Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat. Life Sci 1998;62:PL235-40.
-
(1998)
Life Sci
, vol.62
-
-
Muscara, M.N.1
McKnight, W.2
Del Soldato, P.3
Wallace, J.L.4
-
32
-
-
0032579891
-
Does Helicobacter pylori status affect nonsteroidal antiinflammatory drug-associated gastroduodenal pathology?
-
Malfertheiner P, Labenz J. Does Helicobacter pylori status affect nonsteroidal antiinflammatory drug-associated gastroduodenal pathology? Am J Med 1998;104(Suppl 3A):35S-40S.
-
(1998)
Am J Med
, vol.104
, Issue.SUPPL. 3A
-
-
Malfertheiner, P.1
Labenz, J.2
-
33
-
-
0031906022
-
Canadian Helicobacter pylori consensus conference
-
Canadian Association of Gastroenterology
-
Hunt RH, Thomson AB. Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology. Can J Gastroenterol 1998;12:31-42.
-
(1998)
Can J Gastroenterol
, vol.12
, pp. 31-42
-
-
Hunt, R.H.1
Thomson, A.B.2
-
34
-
-
0030877226
-
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
-
European Helicobacter Pylori Study Group
-
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. Gut 1997;41:8-13.
-
(1997)
Gut
, vol.41
, pp. 8-13
-
-
-
35
-
-
0030044363
-
Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer
-
Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996;110:725-32.
-
(1996)
Gastroenterology
, vol.110
, pp. 725-732
-
-
Labenz, J.1
Tillenburg, B.2
Peitz, U.3
-
36
-
-
0028915876
-
Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole
-
Verdú EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995;36:539-43.
-
(1995)
Gut
, vol.36
, pp. 539-543
-
-
Verdú, E.F.1
Armstrong, D.2
Fraser, R.3
-
37
-
-
0028850461
-
Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole
-
Verdú EF, Armstrong D, Idström JP, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995;37:743-8.
-
(1995)
Gut
, vol.37
, pp. 743-748
-
-
Verdú, E.F.1
Armstrong, D.2
Idström, J.P.3
|